Literature DB >> 21378406

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis.

Turid Heiberg1, Cathrine Austad, Tore K Kvien, Till Uhlig.   

Abstract

OBJECTIVE: Delegates at the Outcome Measures in Rheumatology (OMERACT) 10 conference (Borneo, 4-8 May 2010) questioned how the new seven-domain Rheumatoid Arthritis Impact of Disease (RAID) score performs as a global measure. Score distributions and associations between the RAID score and patient-reported outcomes (PROs) and demographic variables were examined in a large sample of rheumatoid arthritis (RA) patients.
METHODS: 1086 patients in the Oslo RA Register responded to a postal survey with commonly used PROs. Bivariate associations between the RAID score and other measures are reported as Pearson correlation coefficients.
RESULTS: The mean RAID was 3.37 ± 2.17. The distribution of the RAID score showed a slight floor effect: 17.5% had a score between 0 and 1, and 14.4% between 1 and 2, whereas only 1.0% and 0.3% had scores between 8 and 9, and 9 and 10, respectively. Correlations between the RAID score and the patient global assessment, Rheumatoid Arthritis Disease Activity Index, Short-Form (SF)-6D and EQ-5D were 0.82, 0.82, -0.77 and -0.73, respectively. Strong correlation was also seen between RAID and pain, the domain with highest weight, whereas correlations to measures of other RAID domains were moderate. The RAID score was higher in women than men (3.49 vs 2.95, p=0.001).
CONCLUSION: The RAID score was correlated more strongly to other global measures than to PROs, reflecting single health domains.

Entities:  

Mesh:

Year:  2011        PMID: 21378406     DOI: 10.1136/ard.2010.143032

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Patient reported outcomes in rheumatoid arthritis clinical trials.

Authors:  Ana-Maria Orbai; Clifton O Bingham
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.

Authors:  Peter P Cheung; Manjari Lahiri; Lyn March; Laure Gossec
Journal:  Clin Rheumatol       Date:  2016-12-30       Impact factor: 2.980

Review 3.  [Treat-to-target from the patient perspective].

Authors:  E Gromnica-Ihle; M Rink
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

4.  Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.

Authors:  Meltem Alkan Melikoglu; Sebnem Ataman; Hatice Bodur; Hasan Fatih Cay; Erhan Capkin; Ozgur Akgul; Remzi Cevik; Feride Gogus; Ayhan Kamanli; Fatma Gul Yurdakul; Gulcan Gurer; Ilker Yagci; Aylin Rezvani; Mehmet Tuncay Duruoz; Ismihan Sunar
Journal:  Rheumatol Int       Date:  2021-09-24       Impact factor: 2.631

5.  Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database.

Authors:  Katja Thiele; Katinka Albrecht; Angela Zink; Martin Aringer; Kirsten Karberg; Susanna Späthling-Mestekemper; Ulrich von Hinüber; Johanna Callhoff
Journal:  RMD Open       Date:  2022-07

6.  Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation.

Authors:  Sam Norton; Benjamin Ellis; Beatriz Santana Suárez; Samana Schwank; Ray Fitzpatrick; Andrew Price; James Galloway
Journal:  Rheumatology (Oxford)       Date:  2019-01-01       Impact factor: 7.580

7.  Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).

Authors:  Maxime Dougados; Yves Brault; Isabelle Logeart; Désirée van der Heijde; Laure Gossec; Tore Kvien
Journal:  Arthritis Res Ther       Date:  2012-05-30       Impact factor: 5.156

8.  Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care.

Authors:  Fausto Salaffi; Marina Carotti; Marwin Gutierrez; Marco Di Carlo; Rossella De Angelis
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

9.  Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey.

Authors:  Rudolf Puchner; Hans Peter Brezinschek; Josef Fritz; Manfred Herold; Monika Mustak; Thomas Nothnagl; Stephan E Puchner; Andrea Studnicka-Benke; Burkhard F Leeb
Journal:  BMC Musculoskelet Disord       Date:  2015-05-06       Impact factor: 2.362

10.  High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications.

Authors:  Andreas Karabis; Stavros Nikolakopoulos; Shaloo Pandhi; Katerina Papadimitropoulou; Richard Nixon; Ricardo L Chaves; R Andrew Moore
Journal:  Arthritis Res Ther       Date:  2016-03-31       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.